文献速递类风湿关节炎

早期关节炎识别门诊筛查临床关节炎的长期有效性:荷兰单中心纵向队列研究

Long-term effectiveness of the Early Arthritis Recognition Clinic's screening for the presence of clinical arthritis in the Netherlands: a single-centre, longitudinal cohort study.
PubMed 文献 · Lancet Rheumatol · 2026-08-11

该单中心纵向比较有效性队列研究比较了经早期关节炎识别门诊(EARC)转诊与常规途径转诊的类风湿关节炎患者。EARC组5年内疾病活动度更低、功能残疾更少、持续无DMARD缓解率更高,且全科医生延迟更短。结果表明EARC筛查门诊可改善类风湿关节炎的长期结局并减少转诊延迟。

核心结论

  • 实施EARC筛查门诊可改善类风湿关节炎患者的长期结局并减少转诊延迟。

研究设计与样本

  • 单中心纵向比较有效性队列研究,EARC转诊组132例符合条件,纳入122例(2010-2020年招募)。
  • 常规转诊组342例类风湿关节炎患者纳入研究(2006-2009年招募)。
  • 两组均接受相似治疗并在Leiden早期关节炎门诊随访5年。

关键数值与推荐

  • EARC途径共接诊2081例患者,818例有临床关节炎,132例类风湿关节炎符合条件,122例纳入分析(72例女性[59%],50例男性[41%])。
  • 常规转诊途径690例有临床关节炎,其中342例类风湿关节炎纳入研究(225例女性[66%],117例男性[34%])。

临床怎么用

  • 对于疑似类风湿关节炎患者,通过EARC进行关节检查筛查可缩短全科医生延迟并改善5年疾病活动度、功能残疾及持续无DMARD缓解率。

局限性

  • 本研究为单中心纵向比较有效性队列研究,EARC组与常规转诊组招募时间不同(2010-2020年 vs 2006-2009年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: General practitioner (GP) delay is the main cause of referral delay for rheumatoid arthritis in the Netherlands due to insufficient experience with joint examination. This delay led to the launch of the early arthritis recognition clinic, in which rheumatologists screen patients for clinical arthritis using joint examination. Because the long-term effectiveness of this intervention is unknown, we measured functional disability and sustained disease-modifying antirheumatic drug (DMARD)-free remission in patients with rheumatoid arthritis to establish its effectiveness. METHODS: In this single-centre, longitudinal, comparative effectiveness cohort study, patients with rheumatoid arthritis who fulfilled the 1987 criteria, the 2010 criteria, or both of the American College of Rheumatology or European Alliance of Associations for Rheumatology and who were referred through the early arthritis recognition clinic (recruited between 2010 and 2020) were compared with similar patients with rheumatoid arthritis (at least one swollen joint and symptom duration of less than 2 years) referred through regular routes (recruited between 2006 and 2009). Both groups received similar treatment and follow-up for 5 years at the Leiden Early Arthritis Clinic. Outcomes were assessed in all patients. The long-term outcomes of Disease Activity Score (DAS) and functional disability-as measured by the Health Assessment Questionnaire-Disability Index (HAQ-DI)-were analysed by a linear mixed model, and the long-term outcome of sustained DMARD-free remission was analysed with Cox regression. Patients with lived experience of rheumatoid arthritis were involved in the study. FINDINGS: Between Aug 31, 2010, and Jan 2, 2020, 2081 patients were seen via the early arthritis recognition clinic pathway, 818 patients had clinical arthritis and 132 patients with rheumatoid arthritis were eligible. 10 patients were lost to follow-up and 122 were included in the study (72 [59%] female and 50 [41%] male). Between Jan 5, 2006, and De 22, 2009, 690 patients were referred via the regular referral pathway with clinical arthritis of whom 342 had rheumatoid arthritis and were included in the study (225 [66%] female and 117 [34%] male. Patients referred via the early arthritis recognition clinic had lower disease activity (DAS-44) over 5 years (β=0·26 [95% CI 0·12-0·41]; p=0·0003), less functional disability (HAQ-DI) over 5 years (0·14 [0·02-0·25]; p=0·021), and higher rates of sustained DMARD-free remission (hazard ratio 2·1 [95% CI 1·34-3·16]; p=0·0010) compared with regularly referred patients. Patients with rheumatoid arthritis identified via the early arthritis recognition clinic had a lower median GP delay than regularly referred patients (median 5·14 weeks [IQR 1·86-11·43] vs 9·00 weeks [5·00-20·14], p<0·0001). INTERPRETATION: Implementing an EARC screening clinic improved long-term outcomes and reduced referral delays in patients with rheumatoid arthritis. This study is one of the first to indicate that active intervention to accelerate diagnosis seems effective in improving long-term outcomes in patients with rheumatoid arthritis. FUNDING: The Dutch Arthritis Society.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. van Griethuysen SRG, van Mulligen E, van der Helm-van Mil AHM, et al. Long-term effectiveness of the Early Arthritis Recognition Clinic's screening for the presence of clinical arthritis in the Netherlands: a single-centre, longitudinal cohort study. Lancet Rheumatol. 2026. PMID: 42580358. doi:10.1016/S2665-9913(26)00114-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。